{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T10:17:37Z","timestamp":1769595457303,"version":"3.49.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2016,7,23]],"date-time":"2016-07-23T00:00:00Z","timestamp":1469232000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100005972","name":"Deutsche Krebshilfe","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005972","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Immunol Immunother"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1007\/s00262-016-1871-0","type":"journal-article","created":{"date-parts":[[2016,7,23]],"date-time":"2016-07-23T02:51:31Z","timestamp":1469242291000},"page":"1113-1121","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Effector T cell subclasses associate with tumor burden in neurofibromatosis type 1 patients"],"prefix":"10.1007","volume":"65","author":[{"given":"Said","family":"Farschtschi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Su-Jin","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Birgit","family":"Sawitzki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Su-Jun","family":"Oh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lan","family":"Kluwe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victor F.","family":"Mautner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas","family":"Kurtz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,7,23]]},"reference":[{"key":"1871_CR1","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1136\/jmg.26.11.712","volume":"26","author":"SM Huson","year":"1989","unstructured":"Huson SM, Compston DA, Harper PS (1989) A genetic study of von Recklinghausen neurofibromatosis in south east Wales. II. Guidelines for genetic counselling. J Med Genet 26:712\u2013721","journal-title":"J Med Genet"},{"key":"1871_CR2","first-page":"110","volume-title":"Neurofibromatosis. Phenotype, Natural History and Pathogenesis","author":"JM Friedman","year":"1999","unstructured":"Friedman JM, Gutmann DH, MacCollin M, Riccardi VM (1999) Neurofibromatosis. Phenotype, Natural History and Pathogenesis. The Johns Hopkins University Press, Baltimore, pp 110\u2013118"},{"key":"1871_CR3","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.4161\/cc.3.10.1182","volume":"3","author":"MC Harrisingh","year":"2004","unstructured":"Harrisingh MC, Lloyd AC (2004) Ras\/Raf\/ERK signalling and NF1. Cell Cycle 3:1255\u20131258","journal-title":"Cell Cycle"},{"issue":"5","key":"1871_CR4","doi-asserted-by":"crossref","first-page":"634","DOI":"10.2174\/156652409788488801","volume":"9","author":"L Larizza","year":"2009","unstructured":"Larizza L, Gervasini C, Natacci F, Riva P (2009) Developmental abnormalities and cancer predisposition in neurofibromatosis type 1. Curr Mol Med 9(5):634\u2013653","journal-title":"Curr Mol Med"},{"issue":"4","key":"1871_CR5","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1002\/path.1711190402","volume":"119","author":"P Isaacson","year":"1976","unstructured":"Isaacson P (1976) Mast cells in benign nerve sheath tumors. J Pathol 119(4):193\u2013196","journal-title":"J Pathol"},{"issue":"2","key":"1871_CR6","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.jdermsci.2012.04.010","volume":"67","author":"Y Yoshida","year":"2012","unstructured":"Yoshida Y et al (2012) Serum biomarker in neurofibromatosis type 1. J Dermatol Sci 67(2):155\u2013158","journal-title":"J Dermatol Sci"},{"issue":"4","key":"1871_CR7","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1159\/000247170","volume":"188","author":"M N\u00fcrnberger","year":"1994","unstructured":"N\u00fcrnberger M, Moll I (1994) Semiquantitative aspects of mast cells in normal skin and in neurofibromas of\u00a0neurofibromatosis\u00a0types 1 and 5. Dermatology 188(4):296\u2013299","journal-title":"Dermatology"},{"key":"1871_CR8","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1369\/0022155411407340","volume":"59","author":"T Tucker","year":"2011","unstructured":"Tucker T, Riccardi VM, Sutcliffe M, Vielkind J, Wechsler J, Wolkenstein P et al (2011) Different patterns of mast cells distinguish diffuse from encapsulated neurofibromas in patients with neurofibromatosis 1. J Histochem Cytochem 59:584\u2013590","journal-title":"J Histochem Cytochem"},{"issue":"2","key":"1871_CR9","first-page":"129","volume":"17","author":"VM Riccardi","year":"1981","unstructured":"Riccardi VM (1981) Cutaneous manifestation of\u00a0neurofibromatosis: cellular interaction, pigmentation, and mast cells. Birth Defects Orig Artic Ser 17(2):129\u2013145","journal-title":"Birth Defects Orig Artic Ser"},{"issue":"9","key":"1871_CR10","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1056\/NEJM199403033300903","volume":"330","author":"KM Shannon","year":"1994","unstructured":"Shannon KM, O\u2019Connell P, Martin GA, Paderanga D, Olson K, Dinndorf P, McCormick F (1994) Loss of the normal NF1 allele from the bone marrow of children with type 1\u00a0neurofibromatosis\u00a0and malignant myeloid disorders. N Engl J Med 330(9):597\u2013601","journal-title":"N Engl J Med"},{"issue":"11","key":"1871_CR11","doi-asserted-by":"crossref","first-page":"4314","DOI":"10.1182\/blood.V88.11.4314.bloodjournal88114314","volume":"88","author":"DK Miles","year":"1996","unstructured":"Miles DK, Freedman MH, Stephens K, Pallavicini M, Sievers EL, Weaver M, Grunberger T, Thompson P, Shannon KM (1996) Patterns of hematopoietic lineage involvement in children with\u00a0neurofibromatosis\u00a0type 1 and malignant myeloid disorders. Blood 88(11):4314\u20134320","journal-title":"Blood"},{"issue":"2","key":"1871_CR12","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1182\/blood-2009-09-242875","volume":"116","author":"K Staser","year":"2010","unstructured":"Staser K, Yang FC, Clapp DW (2010) Mast cells and the neurofibroma microenvironment. Blood 116(2):157\u2013164","journal-title":"Blood"},{"issue":"3","key":"1871_CR13","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.cell.2008.08.041","volume":"135","author":"FC Yang","year":"2008","unstructured":"Yang FC et al (2008) Nf1-dependent tumors require a microenvironment containing Nf1\u00b1 and c-kit-dependent bone marrow. Cell 135(3):437\u2013448","journal-title":"Cell"},{"issue":"5569","key":"1871_CR14","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1126\/science.1068452","volume":"296","author":"Y Zhu","year":"2002","unstructured":"Zhu Y et al (2002) Neurofibromas in NF1: schwann cell origin and role of tumor environment. Science 296(5569):920\u2013922","journal-title":"Science"},{"issue":"1","key":"1871_CR15","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1172\/JCI66167","volume":"123","author":"K Staser","year":"2013","unstructured":"Staser K, Park SJ, Rhodes SD, Zeng Y, He YZ, Shew MA et al (2013) Normal hematopoiesis and neurofibromin-deficient myeloproliferative disease require Erk. J Clin Invest 123(1):329\u2013334","journal-title":"J Clin Invest"},{"key":"1871_CR16","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1172\/JCI41443","volume":"120","author":"EA Lasater","year":"2010","unstructured":"Lasater EA, Li F, Bessler WK, Estes ML, Vemula S, Hingtgen CM et al (2010) Genetic and cellular evidence of vascular inflammation in neurofibromin-deficient mice and humans. J Clin Invest 120:859\u2013870","journal-title":"J Clin Invest"},{"issue":"5","key":"1871_CR17","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1093\/hmg\/dds502","volume":"22","author":"BK Stansfield","year":"2013","unstructured":"Stansfield BK, Bessler WK, Mali R, Mund JA, Downing B, Li F et al (2013) Heterozygous inactivation of the Nf1 gene in myeloid cells enhances neointima formation via a rosuvastatin-sensitive cellular pathway. Hum Mol Genet 22(5):977\u2013988","journal-title":"Hum Mol Genet"},{"issue":"9","key":"1871_CR18","doi-asserted-by":"crossref","first-page":"e24917","DOI":"10.1371\/journal.pone.0024917","volume":"6","author":"X Wu","year":"2011","unstructured":"Wu X, Chen S, He Y, Rhodes SD, Mohammad KS, Li X, Yang X, Jiang L, Nalepa G, Snider P, Robling AG, Clapp DW, Conway SJ, Guise TA, Yang FC (2011) The haploinsufficient hematopoietic microenvironment is critical to the pathological fracture repair in murine models of\u00a0neurofibromatosis\u00a0type 1. PLoS One 6(9):e24917","journal-title":"PLoS One"},{"issue":"1","key":"1871_CR19","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1097\/NEN.0b013e3182032d37","volume":"70","author":"GW Simmons","year":"2011","unstructured":"Simmons GW et al (2011) Neurofibromatosis-1 heterozygosity increases microglia in a spatially and temporally restricted pattern relevant to mouse optic glioma formation and growth. J Neuropathol Exp Neurol 70(1):51\u201362","journal-title":"J Neuropathol Exp Neurol"},{"issue":"10","key":"1871_CR20","doi-asserted-by":"crossref","first-page":"3656","DOI":"10.1182\/blood-2002-03-0734","volume":"100","author":"DA Ingram","year":"2002","unstructured":"Ingram DA, Zhang L, McCarthy J, Wenning MJ, Fisher L, Yang FC, Clapp DW, Kapur R (2002) Lymphoproliferative defects in mice lacking the expression of neurofibromin: functional and biochemical consequences of Nf1 deficiency in T-cell development and function. Blood 100(10):3656\u20133662","journal-title":"Blood"},{"issue":"3\u20134","key":"1871_CR21","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.molimm.2013.03.005","volume":"55","author":"JA Oliver","year":"2013","unstructured":"Oliver JA, Lapinski PE, Lubeck BA, Turner JS, Parada LF, Zhu Y, King PD (2013) The Ras GTPase-activating protein\u00a0neurofibromin 1\u00a0promotes the positive selection of thymocytes. Mol Immunol 55(3\u20134):292\u2013302","journal-title":"Mol Immunol"},{"issue":"5","key":"1871_CR22","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1038\/jid.2012.488","volume":"133","author":"DE Reuss","year":"2013","unstructured":"Reuss DE, Mucha J, Holtkamp N, M\u00fcller U, Berlien HP, Mautner VF et al (2013) Functional MHC Class II Is upregulated in neurofibromin-deficient schwann cells. J Invest Dermatol 133(5):1372\u20131375","journal-title":"J Invest Dermatol"},{"key":"1871_CR23","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1186\/1741-7015-11-109","volume":"11","author":"SJ Park","year":"2013","unstructured":"Park SJ, Sawitzki B, Kluwe L, Mautner VF, Holtkamp N, Kurtz A (2013) Serum biomarkers for neurofibromatosis type 1 and early detection of malignant peripheral nerve sheath tumors. BMC Med 11:109","journal-title":"BMC Med"},{"key":"1871_CR24","doi-asserted-by":"crossref","first-page":"5677","DOI":"10.1158\/1078-0432.CCR-03-0769","volume":"10","author":"GA Mashour","year":"2004","unstructured":"Mashour GA, Driever PH, Hartmann M, Drissel SN, Zhang T, Scharf B et al (2004) Circulating growth factor levels are associated with tumorigenesis in neurofibromatosis type 1. Clin Cancer Res 10:5677\u20135683","journal-title":"Clin Cancer Res"},{"key":"1871_CR25","doi-asserted-by":"crossref","first-page":"3763","DOI":"10.1158\/1078-0432.CCR-03-0712","volume":"10","author":"P L\u00e9vy","year":"2004","unstructured":"L\u00e9vy P, Bi\u00e8che I, Leroy K, Parfait B, Wechsler J, Laurendeau I et al (2004) Molecular profiles of neurofibromatosis type 1-associated plexiform neurofibromas: identification of a gene expression signature of poor prognosis. Clin Cancer Res 10:3763\u20133771","journal-title":"Clin Cancer Res"},{"issue":"1","key":"1871_CR26","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1189\/jlb.0809566","volume":"87","author":"D Focosi","year":"2010","unstructured":"Focosi D, Bestagno M, Burrone O, Petrini M (2010) CD57+ T lymphocytes and functional immune deficiency. J Leukoc Biol 87(1):107\u2013116","journal-title":"J Leukoc Biol"},{"key":"1871_CR27","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/B978-0-444-52902-2.00053-9","volume":"115","author":"RE Ferner","year":"2013","unstructured":"Ferner RE, Gutmann DH (2013) Neurofibromatosis type 1 (NF1): diagnosis and management. Handb Clin Neurol 115:939\u2013955","journal-title":"Handb Clin Neurol"},{"key":"1871_CR28","unstructured":"Hematology: Clinical Principles and Applications. By Bernadette F. Rodak, George A. Fritsma, Elaine Keohane, ELSEVIER Saunters. 3251 Riverport Ln, St Louis, Missouri 63043, (2012) ISBN 978-1-4377-0692-5"},{"issue":"4","key":"1871_CR29","doi-asserted-by":"crossref","first-page":"e35711","DOI":"10.1371\/journal.pone.0035711","volume":"7","author":"SR Plotkin","year":"2012","unstructured":"Plotkin SR, Bredella MA, Cai W, Kassarjian A, Harris GJ, Esparza S et al (2012) Quantitative assessment of whole-body tumor burden in adult patients with neurofibromatosis. PLoS One 7(4):e35711","journal-title":"PLoS One"},{"issue":"4","key":"1871_CR30","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1215\/15228517-2008-011","volume":"10","author":"VF Mautner","year":"2008","unstructured":"Mautner VF, Asuagbor FA, Dombi E, F\u00fcnsterer C, Kluwe L, Wenzel R et al (2008) Assessment of benign tumor burden by whole-body MRI in patients with neurofibromatosis 1. Neuro Oncol 10(4):593\u2013598","journal-title":"Neuro Oncol"}],"container-title":["Cancer Immunology, Immunotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-016-1871-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00262-016-1871-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-016-1871-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,24]],"date-time":"2020-09-24T07:48:41Z","timestamp":1600933721000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00262-016-1871-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7,23]]},"references-count":30,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2016,9]]}},"alternative-id":["1871"],"URL":"https:\/\/doi.org\/10.1007\/s00262-016-1871-0","relation":{},"ISSN":["0340-7004","1432-0851"],"issn-type":[{"value":"0340-7004","type":"print"},{"value":"1432-0851","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,7,23]]}}}